Navigation Links
New England Journal of Medicine Publishes New Data on Gardasil,,Merck's Cervical Cancer Vaccine

th respect to prevalence of HPV infection and disease at enrollment. Analyses were conducted to evaluate the overall impact of GARDASIL with respect to HPV 6-, 11-, 16-, and 18-related cervical and genital disease in the general population. Here, analyses included events arising from HPV infections that were present at the start of vaccination as well as events that arose from infections that were acquired after the start of vaccination. The impact of GARDASIL in the general population is shown in Table 2. Impact was measured starting 1 month Postdose 1. Prophylactic efficacy denotes the vaccine's efficacy in women who are naive (PCR negative and seronegative) to the relevant HPV types at vaccination onset. General population impact denotes vaccine impact among women regardless of baseline PCR status and serostatus. The majority of CIN and genital warts, VIN, and VaIN detected in the group that received GARDASIL occurred as a consequence of HPV infection with the relevant HPV type that was already present at Day 1. Table 2 General Population Impact for Vaccine HPV Types ---------------------------------------------------------------------- GARDASIL or HPV 16 L1 Placebo VLP Vaccine % Reduction Endpoints Analysis ---------------------- (95% CI) N Cases N Cases ====================================================================== Prophylactic Efficacy* 9342 1 9400 81 98.8 (92.9, 100.0) ----------------------------------------------------- HPV 16- or 18- HPV 16 related CIN 2/3 and/or HPV or AIS 18 Positive at Day 1 -- 121 -- 120 -- ----------------------------------
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
2. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
3. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
4. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
5. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
6. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
7. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
8. Genetics Journal Thimerosal/Autism Study the Best Science Drug Company Money Can Buy
9. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
10. Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
11. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics

Post Your Comments:
(Date:11/25/2009)...XTON,Pa.,Nov.25/PRNewswire/--BioTrendsResearchGrou...lara report,thefirstinamulti-phasesyndicatedmarke...iotech,sStelara,fromproductlaunchthroughthefirstsi...uantitativeinformationfrom75uniqueDermatologistsan...ssesstrialanduseofStelara,obstaclestouse,typicalpa...
(Date:11/25/2009)..., COLLEGE PARK, Md., Nov. 25 /PRNewswire-USNews...eloping a shaving cream-like foam that stops sever...t Promising Security Idea category of the Global S... today. ,, Selected from more than 100 entries ...ir invention at the GSC Security Summit conference...
(Date:11/25/2009)... , HARBIN, China, Nov. 25 /PRNewswire-Asi...a Sky One Medical" or "the Company") (Nasdaq: CSK...pany developing and producing,over-the-counter dru...y,announced that the Company recently passed the C...aceutical and Biological Products ("ICPBP") examin...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Strong link found between concussions and brain tissue injury 55150 1Strong link found between concussions and brain tissue injury 55150 2Strong link found between concussions and brain tissue injury 55150 3Searching for an interglacial on Greenland 9684 1Searching for an interglacial on Greenland 9684 2Diplomat Specialty Pharmacy Partners With CareSource Launches Chronic Kidney Disease Management Program with Ohio Plan 55146 1Diplomat Specialty Pharmacy Partners With CareSource Launches Chronic Kidney Disease Management Program with Ohio Plan 55146 2
...Lower Incidence of Severe Cardiac Toxicity With Eq...s Reported, ATLANTA, Dec. 11 Cell Therapeutics, ... that preliminary data from,its phase II/III rando...t-line treatment of patients with aggressive non-H...ed pixantrone experienced less severe,(grade 3/4) ...
...tion aimed at enabling vaccine production facility...tional egg-based facility., * Once established, s...f, pandemic flu vaccine to commence within 12 wee...gland and ROCKVILLE, Md., Dec. 10, GE Healthcare, ...nd Novavax Inc. (Nasdaq: NVAX ), today announced ...
Other Medicine Technology:Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 2Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 3Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 4Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 5GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution 2GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution 3GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution 4
(Date:11/27/2009)... The Gymboree Corporation...O/COO, will present at the NASDAQ OMX 23rd Investo...l in London, England, on Wednesday, December 2, 20...roadcast of The Gymboree Corporation,s presentatio....com, click on "Our Company" at the bottom of the ...
(Date:11/27/2009)... Holdings has announced that it has become a natio...e largest nonprofit organizations dedicated to art... Delray Beach, FL (Vocus) Nov...XCHO), a company specializing in the marketing and...ts, has announced today that is has become a natio...
(Date:11/27/2009)...ealth™ announced today that Spectrum Health ...d Enterprise orthopedic templating solution and it... (PRWEB) November 27, 2009 -- Voyant...h (Grand Rapids, Michigan) has licensed its Trauma...its TraumaCad Extend workflow solution, to allow i...
(Date:11/26/2009)...ewswire/ -- With cold and flu season upon us, it,s... to control the spread of infections and avoid ill...eep ourselves healthy, but to avoid transmitting i..., CIC (certified in infection-control), nursing di...th at Hospital for Special Surgery (HSS) in Manhat...
(Date:11/26/2009)...y can lead to strains or worse , , THURS...ing wrong with stuffing your turkey full to bursti...th your suitcase as you pack for holiday trips. ,... U.S. hospital emergency rooms, doctors, offices, ...elated injuries, such as muscle strains, pulls and...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Pack Right for the Holidays to Avoid the ER 2
...e heart failure is the most frequent cause of hosp...ult to diagnose.// Treatment delays increase the c...sts of care. Already, doctors in many emergency...ch the heart stops pumping effectively. The su...
...lure is a chronic but deadly condition caused by t...ually enlarges as it becomes weaker and weaker. ...n, which will kill half of them within five years....ients who took statins ( work by reducing inflamma...
...rch shows older women with depression may have an ...archers in New York studied more than 93,600 older...iative Observational Study (WHI-OS). The WHI-OS is...ealth conditions. For this study, participants wer...
...d, skin cancers cause 16,000 deaths each year due ... body. // Previously, the best way to predict whe...g its thickness. It was believed the thicker a tum... found a new way to predict whether skin cancers w...
... to a recent study by Taiwanese experts , people b...getting virtually none. St John's Wort, or Hype...ugh doctors warn it can interfere with the effects... to be responsible for the psychoactive effects of...
...sia usually occurs without warning when a woman de...nancy.// About 5 percent of pregnant women are aff...e protein in their urine. If the condition progres...ndition, only delivery of the baby can resolve the...
Other Medicine News:Health News:‘Protein’ Produced By Overstressed Heart Muscle a Strong Indicator Of Heart Disea 2Health News:Predicting The Risk Of Preeclampsia During Pregnancy 2
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
Medicine Products: